J Nutr by Fazili, Zia et al.
The loss of 5-methyltetrahydrofolate in human serum under 
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Abstract
Background—Maintaining folate stability during sample handling is important, yet challenging.
Objective—We investigated the effects of suboptimal preanalytical conditions on serum folate 
stability.
Design—Using an HPLC-tandem MS method we measured folates [5-methyltetrahydrofolate (5-
methylTHF), folic acid, and MeFox (5-methylTHF oxidation product), minor forms at or below 
limit of detection] in human serum exposed to suboptimal conditions.
Results—Whole blood samples (n = 21) stored at 32°C for ≤3 d (experiment 1 – delayed 
processing) showed significant decreases in serum total folate [(tFOL; sum of folate forms) 11–
32%, 5.5–15.9 nmol/L] and 5-methylTHF (36–62%, 14.5–25.1 nmol/L) and a significant increase 
in MeFox (346–415%, 7.17–8.63 nmol/L). Serum samples (n = 21) stored at 11°C for 7–14 d 
(experiment 2 – delayed freezing) also showed significant decreases in tFOL (4.6–10.4%, 2.3–5.1 
nmol/L) and 5-methylTHF (8.4–29%, 3.4–11.6 nmol/L) and significant increases in MeFox (88–
320%, 1.82–6.62 nmol/L). The molar loss in 5-methylTHF exceeded the gain in MeFox in these 2 
experiments. When we exposed 3 serum pools (tFOL 16.7–58.3 nmol/L) for 24 h to 37°C elevated 
temperature (experiment 3), the significant decrease in 5-methylTHF (33% on average) was 
compensated by an equimolar gain in MeFox. Repeated freeze/thawing (≤3 cycles) of serum 
[closed (experiment 4) and open (experiment 5) vials] showed generally stable folates with small 
(<1 nmol/L) changes. Long-term (≤12 mo) exposure of 3 serum pools (tFOL 17.5–63.7 nmol/L) to 
suboptimal (−20°C) freezing temperature (experiment 6) showed significant decreases in tFOL 
(5% on average) already after 3 mo. The molar loss in 5-methylTHF exceeded the gain in MeFox. 
Folic acid generally showed good stability.
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Conclusions—To avoid folate losses, unprocessed whole blood should be protected from 
elevated temperature and serum should not be refrigerated for >2 d or long-term stored at −20°C.
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INTRODUCTION
Suboptimal environmental conditions during preanalytical steps such as sample collection, 
processing, shipping, and storage can negatively affect analytical results. Knowledge about 
analyte stability during these steps is therefore critical. Serum folate is an important 
biomarker of folate status and it has been measured as part of the U.S. NHANES for several 
decades (1). While the susceptibility of reduced folates to oxidative degradation is well-
known (2,3), only limited information is available on the behavior of serum folate forms 
during the full spectrum of preanalytical conditions. Hannisdal et al. have so far provided 
extensive information on the oxidative loss of 5-methyltetrahydrofolate (5-methylTHF)4, the 
major circulating portion of total folate (tFOL), to the pyrazino-s-triazine derivative of 4α-
hydroxy-5-methylTHF [also known as MeFox (4)], in a short-term (1 wk) kinetic study of 
serum and plasma exposed to room temperature (5) and in a long-term (up to 29 y) cross-
sectional study of serum frozen at suboptimal (−25°C) temperature (6). Our group has 
provided information on a broad range of micronutrients, including serum tFOL measured 
by microbiologic assay, for 2 unfavorable preanalytical conditions that may be encountered 
in resource-limited situations: delayed processing of whole blood exposed to elevated 
temperature sometimes encountered in the field (32°C) for up to 3 d and delayed freezing of 
serum exposed to slightly cooled temperature achievable with cold packs (11°C) for up to 14 
d (7).
The main objective of the present study was to investigate the effects of a series of 
suboptimal preanalytical conditions on folate stability, covering the full spectrum from 
whole blood processing to repeated freeze/thawing of samples as part of the laboratory 
analysis. Serum folate forms were measured with a sensitive and specific HPLC-tandem MS 
(HPLC-MS/MS) method (4,8,9) in a series of experiments: experiment 1 – delayed (≤3 d) 
processing of freshly collected whole blood incubated at 32°C; experiment 2 – delayed (≤14 
d) freezing of freshly obtained serum stored at 11°C; experiment 3 – short-term (≤24 h) 
exposure of serum to elevated temperature (room temperature and 37°C); experiments 4 and 
5 – repeated (≤3 cycles) freeze/thawing of serum in either closed or open vials; experiments 
6 and 7 – long-term (≤12 mo) exposure of serum to suboptimal storage temperatures (−20°C 
and 5°C). Results from this study will help to refine preanalytical procedures and therefore 
improve the measurement accuracy of serum folate forms.
4Abbreviations used: 5-formylTHF, 5-formyltetrahydrofolate; 5,10-methenylTHF, 5,10-methenyltetrahydrofolate; 5-methylTHF, 5-
methyltetrahydrofolate; HPLC-MS/MS, HPLC-tandem MS; MeFox, pyrazino-s-triazine derivative of 4α-hydroxy-5-
methyltetrahydrofolate; QC, quality control; THF, tetrahydrofolate.
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REAGENTS, MATERIALS, AND SERUM SAMPLES
Folate monoglutamate standards [(6S)-5-methylTHF, (6S)-MeFox, folic acid, (6S)-
tetrahydrofolate (THF), (6S)-5-formyltetrahydrofolate (5-formylTHF), and (6R)-5,10-
methenyltetrahydrofolate (5,10-methenylTHF)] together with their 13C5-labeled analogues 
were purchased from Merck Cie (Switzerland). All other reagents and solvents were of ACS 
grade (4,8,9). We used in-house prepared quality control (QC) pools using serum purchased 
from a U.S. blood bank. Other serum samples were from a CDC study using volunteer blood 
collection (7), and from a large CDC study (convenience samples). Participants for both 
studies provided informed consent and the study protocols were approved by the CDC 
Institutional Review Board and the CDC Research Ethics Review Board.
Sample processing for preanalytical experiments
All preanalytical experiments are described in Table 1 and additional information to 
experiments 1 and 2 has been presented previously (7). Folate calibrators for 5-methylTHF, 
folic acid, THF, 5-formylTHF, 5,10-methenylTHF, and MeFox and their respective 13C5-
labeled internal standards were prepared as described earlier (8–9). To measure serum folate 
forms, we processed samples using an automated reversed phase solid phase extraction 
method and analyzed sample extracts (all conditions from the same study participant in the 
same run) by HPLC-MS/MS (4). For experiments 6 and 7 (conducted earlier) we used our 
previous HPLC-MS/MS method (8,9), which did not separate the 2 isobaric compounds 
MeFox and 5-formylTHF. Because we spiked the serum QC pools used in those 2 
experiments with 5-formylTHF at the time of pool preparation and we confirmed the target 
concentrations more recently with our updated HPLC-MS/MS method (which separates 
MeFox and 5-formylTHF via different mass transitions), we were able to subtract the 
correctly measured 5-formylTHF amount from the sum of MeFox and 5-formylTHF 
measured in experiments 6 and 7 to obtain an estimate for MeFox. All sample processing 
steps were conducted under gold fluorescent lights. To evaluate the quality of the analytical 
run, each run included 3 serum QC samples measured in duplicate, bracketing the unknown 
samples. We calculated serum tFOL as the sum of the individual folate forms including 
MeFox [using an imputed value of limit of detection (LOD) divided by the square root of 2 
for results <LOD]. We are not reporting results for the 2 minor folate forms 5-formylTHF 
and 5,10-methenylTHF because their concentrations were <LOD. We are only reporting 
THF results in the text when concentrations were >LOD.
Statistical analysis
Statistical analyses were performed using SAS (version 9.2, SAS Institute Inc., Cary, NC) 
software. We used a log10 transformation to account for the right-skewed distributions and 
for the increasing variance with increasing folate concentration. We calculated least squares 
geometric mean concentrations using back-transformation (95% CI) for folate forms using 
1-way (time) or 2-way (time and pool) ANOVA, depending on the experiment (Table 1). As 
a consequence of the log transformation, differences relative to the reference condition were 
expressed as percent change of geometric means (95% CI) rather than an absolute difference 
in log transformed values and evaluated for significance in pairwise comparisons using a 2-
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sided level of α = 0.05. If the interaction between time and pool was significant 
(experiments 3 and 6 for MeFox), we reported the percent change results separately for each 
pool; otherwise we reported the mean percent change across the 3 pools. To facilitate the 
interpretation of molar changes in 5-methylTHF vs. MeFox, we also calculated the absolute 
change in geometric mean concentrations.
RESULTS
Experiment 1 – Delayed processing of whole blood
Freshly collected whole blood samples (n = 21) stored at 32°C for 1–3 d prior to processing 
showed substantial and significant decreases in serum tFOL (5.5–15.9 nmol/L, up to ~30%) 
and 5-methylTHF (14.5–25.1 nmol/L, up to ~60%) and increases in MeFox (7.17–8.63 
nmol/L, up to ~400%) (Table 2 and Supplemental Figure 1, panels A and B). The gain in 
MeFox represented only a fraction of the loss in 5-methylTHF at either time point. Serum 
folic acid concentrations were stable under these conditions. Serum THF concentrations 
(0.647 nmol/L at baseline) decreased by ~0.1–0.4 nmol/L (data not shown).
Experiment 2 – Delayed freezing of serum
Freshly prepared serum samples (n = 21) kept for 2 d at 11°C showed no change in tFOL or 
5-methylTHF, but a small and significant increase in MeFox (0.38 nmol/L) (Table 3 and 
Supplemental Figure 1, panels C and D). Longer delays in freezing serum samples (7–14 d) 
resulted in moderate-to-substantial significant decreases in tFOL (2.3–5.1 nmol/L, up to 
~10%) and 5-methylTHF (3.4–11.6 nmol/L, up to ~30%) and increases in MeFox (1.82–
6.62 nmol/L, up to ~300%). The gain in MeFox only partially compensated for the loss in 5-
methylTHF. The decrease in serum folic acid was significant but small (≤0.17 nmol/L, 
~5%). Serum THF concentrations (0.647 nmol/L at baseline) also decreased by ~0.2–0.3 
nmol/L (data not shown).
Experiment 3 – Short-term exposure of serum to elevated temperatures
We found good stability of 5-methylTHF in 3 serum QC pools stored up to 24 h at room 
temperature and up to 6 h at 37°C, but we noted a significant average decrease of ~30% at 
24 h (4.2, 10.8, and 17.0 nmol/L decrease for the low, medium, and high pool, respectively) 
(Supplemental Table 1). MeFox concentrations were fairly stable up to 6 h at room 
temperature, but increased significantly at 24 h by 0.83–2.56 nmol/L depending on the pool 
(P-interaction = 0.0072). At 37°C, MeFox concentrations increased continually with time 
(e.g., 4.57, 10.5, and 16.3 nmol/L increase at 24 h for the low, medium, and high pool, 
respectively; P-interaction = 0.0013). At both temperatures, the molar gain in MeFox was of 
similar magnitude as the loss in 5-methylTHF at 24 h (Fig. 1). Serum folic acid and tFOL 
concentrations were stable under these conditions (small but significant fluctuations in tFOL 
of ≤6%).
Experiments 4 and 5 – Repeated freeze/thawing of serum
We first subjected 3 serum QC pools in closed vials (sample not exposed to air) to up to 3 
freeze/thawing cycles. Compared to serum QC pools that were thawed only once, we found 
no loss of tFOL and 5-methylTHF, and only a small but significant increase in folic acid (≤1 
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nmol/L, 5%) after 3 freeze/thawing cycles and significant increases in MeFox (0.12–0.96 
nmol/L, up to ~25%) at 1, 2, and 3 freeze/thawing cycles (Table 4). Next, we subjected 30 
pooled serum samples (each pool was generated from several individual samples to provide 
sufficient volume) to 4 subsequent analyses (Table 5). This resulted in each pooled sample 
being opened 4 times and exposed to air for 2 h each. Under these conditions we found a 
small but significant decrease in tFOL (1.4 nmol/L, ~3%) after 3 freeze/thawing cycles and 
small but significant changes in 5-methylTHF and MeFox at 1, 2, and 3 freeze/thawing 
cycles. However, the gain in MeFox (≤0.3 nmol/L) only partially compensated for the loss in 
5-methylTHF (0.9–1.5 nmol/L). We noted small (<0.2 nmol/L) fluctuations in folic acid and 
THF (significant at 2 and 3 freeze/thawing cycles).
Experiments 6 and 7 – Long-term storage of serum at suboptimal conditions
When we stored 3 serum QC pools at −20°C for 3, 6, 9, and 12 mo (Table 6), we observed a 
continuous and significant decrease in tFOL (4.91%, 8.64%, 10.2%, and 12.2%, 
respectively; corresponding to 0.7–2.2, 2.0–5.1, and 3.8–7.5 nmol/L for the low, medium, 
and high QC pool, respectively) and 5-methylTHF (9.58%, 16.6%, 18.7%, and 20.9%, 
respectively; corresponding to 1.1–3.0, 3.7–7.1, and 4.7–10 nmol/L for the low, medium, 
and high QC pool, respectively), irrespective of the folate baseline concentration. We 
observed a significant increase in MeFox up to 6 mo followed by a plateauing of 
concentrations in all 3 QC pools (P-interaction = 0.0299): low QC: 0.41, 0.82, 0.87, and 0.80 
nmol/L or 66.9%, 134%, 142%, and 131%, respectively; medium QC: 1.59, 2.04, 1.94, and 
2.01 nmol/L or 187%, 239%, 227%, and 235%, respectively; high QC: 1.19, 2.80, 2.67, and 
2.54 nmol/L or 63%, 148%, 141%, and 134%, respectively. The molar gain in MeFox made 
up only a fraction of the loss in 5-methylTHF. Serum folic acid concentrations did not 
change over the 12 mo storage period. Storing serum at 5°C for 6 and 12 mo (Supplemental 
Table 2) led to significant and drastic changes: approximately half and 2/3 of tFOL was lost 
and approximately ¾ and almost all of 5-methylTHF was lost, respectively. Even though 
MeFox concentrations nearly quadrupled after 6 mo, the gain in MeFox only compensated 
for a small fraction of the loss in 5-methylTHF. Under these drastic storage conditions we 
also found a significant but small decrease in serum folic acid at 12 mo (6.61%).
DISCUSSION
The present study investigated changes in serum folate forms in response to a series of 
suboptimal preanalytical experiments on folate stability, covering the full spectrum from 
whole blood processing to repeated freeze/thawing of samples as part of the laboratory 
analysis. Because 5-methylTHF makes up the major portion of circulating folates (10) and it 
is susceptible to oxidative degradation to MeFox (11), a folate form that is detected in most 
serum samples (4) but is biologically inactive (12), it is critical to understand how these 2 
folate forms behave under preanalytical conditions. Folic acid is another important 
component in serum samples, especially in populations that are exposed to folic acid-
fortified foods (10), but this vitamer is generally believed to have good stability (2,13). Not 
much is known about the stability of minor folate forms (THF, 5-formylTHF, and 5,10-
methenylTHF) during suboptimal preanalytical conditions, particularly because these 
vitamers are present in serum at low concentrations and often not detectable. However, 
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during analysis these folates are known to be either sensitive to oxidation or subject to 
interconversions (2,13).
The notable loss of 5-methylTHF during delayed processing of whole blood, 14.5 nmol/L 
(36%) after only 1 d at 32°C, was similar to the loss of tFOL (12.9 nmol/L or 30%) we 
reported earlier from the microbiologic assay for the same set of samples (7). This is 
expected because the microbiologic assay does not respond to MeFox. The tFOL measured 
by our HPLC-MS/MS included MeFox and as a result decreased by only 5.5 nmol/L (11%). 
A previous report on a 1 d serum-clot contact time at 32°C reported only a 15% loss of tFOL 
measured by a radioimmunoassay (14). This brings up the question whether the latter assay 
may have responded to MeFox and it emphasizes that findings obtained with one method 
have to be carefully interpreted and cannot necessarily be applied to another. Also, more 
research is needed to investigate whether different clinical folate assays respond to MeFox.
As expected, the loss of 5-methylTHF was more moderate when serum was stored at 11°C 
(3.4, 5.7, and 11.6 nmol/L after 7 d, 10 d, and 14 d, respectively) and similar to the loss of 
tFOL (1.9, 4.0, and 10.6 nmol/L) we reported earlier from the microbiologic assay (7). 
However, the large increase in MeFox, 1.82–6.62 nmol/L when serum was stored 7–14 d at 
11°C and 7.17–8.63 nmol/L when unprocessed whole blood was stored 1–3 d at 32°C, did 
not compensate for the loss of 5-methylTHF. This means that while capturing MeFox as part 
of tFOL is important, it does not guarantee that all folate that was originally in the sample is 
accounted for. Following proper preanalytical conditions that protect labile folates is still 
important.
While the room temperature condition in our experiment on short-term exposure of serum to 
elevated temperature was similar to the kinetic study conducted by Hannisdal et al. (5) and 
confirmed their findings [5-methylTHF was stable at room temperature for 24 h (our study) 
and 48 h (5)], the 37°C condition was new and added to the previous findings [33% loss of 
5-methylTHF after 1 d at 37°C (our study) vs. 50% loss of 5-methylTHF after 8 d at room 
temperature (5)]. Our observation that the 5-methylTHF loss after 1 d at either room 
temperature or 37°C was recovered by MeFox was similar to the conclusion by Hannisdal et 
al. that the 5-methylTHF loss within 2 d at room temperature was recovered by MeFox (5). 
This indicates that a limited exposure of serum to moderate temperature does not 
compromise the quantitation of tFOL as long as MeFox is also measured as part of the 
tFOL.
The stability of folates during repeated freeze/thawing of serum is of great concern because 
analyses sometimes have to be repeated due to a run being out of control or specific results 
violating predetermined sample QC criteria. We confirmed previous findings that folates are 
relatively stable (<5% loss) when exposed to a limited number of short freeze/thawing 
cycles. Pfeiffer et al. (9) found no loss of folates when serum was briefly (1 h) subjected to 3 
freeze/thawing cycles at room temperature, but found some folate loss (~10%) when 
samples were kept at room temperature for extended time (5 h). Similarly, Drammeh et al. 
found some folate loss (<5%) when serum was subjected to 3 freeze/thawing cycles (7). The 
moderate increase in MeFox (<1 nmol/L) in the absence of a loss of 5-methylTHF we 
observed in the “closed vial” experiment 4 may be due to the structural rearrangement of 
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residual 4α-hydroxy-5-methylTHF (the intermediary product in the oxidation of 5-
methylTHF) to MeFox.
Only sparse information is available on long-term storage stability of folates (15), 
particularly at suboptimal temperatures, which is the case if the laboratory does not have 
access to a low temperature freezer. Good stability of folates in serum or plasma containing 
ascorbic acid (5 g/L) stored at −20°C for years was reported (16). On the other hand, a 20% 
decrease of folate was noted in serum samples (without added ascorbic acid) stored at −20°C 
for 1 y with no further decrease thereafter for up to 4 y (17). This was similar to our finding 
of 21% loss of 5-methylTHF when we stored serum QC samples (without added ascorbic 
acid) at −20°C for 1 y. One study reported an even higher (40%) loss of folate after serum 
storage at −20°C for 1 mo, but levels remained stable afterwards for 1 y (18). The doubling 
to tripling of MeFox concentrations in our experiment 6 (serum storage at −20°C for 1 y) 
was not able to compensate the molar loss of 5-methylTHF and confirmed findings by 
Hannisdal et al. who investigated the analytical recovery of folate and its degradation 
products during long-term storage of serum at −25°C for up to 29 y (6). While the authors 
found MeFox in all specimens, this oxidation product did not compensate for the complete 
loss of folate; substantial folate degradation was recovered as para-aminobenzoylglutamate. 
Not surprisingly, we found drastic 5-methylTHF losses when serum was stored at 5°C for up 
to 1 y, yet only 7% loss of folic acid. Folic acid showed good stability during frozen storage 
at −20°C for 1 y, but also during most other preanalytical experiments in our study.
Our study has several strengths. We covered a broad range of preanalytical conditions, 
including some extreme conditions that are rarely reported in the literature. The analyses 
were conducted with a sensitive, specific, and precise HPLC-MS/MS method. To enhance 
the power of our study, we either analyzed >20 individual samples per condition or we 
analyzed several replicates (>4) of the same pool per condition. A limitation of our study is 
that we did not apply a consistent design to all experiments. This was because we relied on 
already available and unique sample sets for some experiments (7), while for others we 
relied on well-characterized serum QC pools. It would have been desirable to also obtain 
information on the behavior of minor folate forms, however this is limited by the fact that in 
most samples those vitamer forms are not detectable.
In conclusion, the current study provides valuable information for the design of field studies. 
Our findings reemphasize that sample processing and storage time and temperature are 
critical parameters that influence serum folate stability and the accuracy of results. Prompt 
processing of whole blood and storage of serum at optimal temperature (−70°C) is critical to 
prevent the loss of folate and the oxidation of 5-methylTHF to MeFox. While the 
quantitation of MeFox in optimally collected, processed, and stored samples is critical to 
compensate for minor losses of 5-methylTHF during preanalytical steps, MeFox may not 
completely recover the loss of 5-methylTHF, especially when samples have undergone more 
extreme suboptimal processing and storage conditions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Effect of short-term (≤24 h) exposure of serum QC pools to elevated temperature (room 
temperature and 37°C) on concentrations of 5-methylTHF (panel A) and MeFox (panel B). 
Values are geometric means from 4 replicates/condition. Error bars represent the 95% CI. 5-
methylTHF, 5-methyltetrahydrofolate; MeFox, pyrazino-s-triazine derivative of 4α-
hydroxy-5-methyltetrahydrofolate; QC, quality control; RT, room temperature.
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